Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry)

Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry)

Temporary interruption of dual antiplatelet therapy (DAPT) is not infrequently required in patients undergoing percutaneous coronary intervention (PCI). We sought to describe the procedures and outcomes associated with DAPT interruption in patients treated with DAPT following successful PCI from the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 2017-09, Vol.120 (6), p.904-910
Hauptverfasser: Schoos, Mikkel, Chandrasekhar, Jaya, Baber, Usman, Bhasin, Aarti, Sartori, Samantha, Aquino, Melissa, Vogel, Birgit, Farhan, Serdar, Sorrentino, Sabato, Kini, Annapoorna, Kruckoff, Mitchell, Moliterno, David, Henry, Timothy D., Weisz, Giora, Gibson, C. Michael, Iakovou, Ioannis, Colombo, Antonio, Steg, P. Gabriel, Witzenbichler, Bernhard, Chieffo, Alaide, Cohen, David, Stuckey, Thomas, Ariti, Cono, Dangas, George, Pocock, Stuart, Mehran, Roxana
Format: Artikel
Sprache:eng
Schlagworte:
Acute coronary syndromes
Adhesion
Aged
Antiplatelet therapy
Aspirin
Aspirin - therapeutic use
Clopidogrel
Coronary Artery Disease - therapy
Drug Therapy, Combination
Female
Follow-Up Studies
Heart attacks
Heart surgery
Humans
Interruption
Intervention
Male
Medication Adherence
Middle Aged
Patients
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors - therapeutic use
Platelets
Preoperative Care - methods
Prospective Studies
Registries
Retrospective Studies
Stents
Studies
Surgery
Therapy
Thrombosis
Ticlopidine - analogs & derivatives
Ticlopidine - therapeutic use
Time Factors
Withholding Treatment
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Temporary interruption of dual antiplatelet therapy (DAPT) is not infrequently required in patients undergoing percutaneous coronary intervention (PCI). We sought to describe the procedures and outcomes associated with DAPT interruption in patients treated with DAPT following successful PCI from the Patterns of non-adherence to anti-platelet regimens in stented patients registry (n = 5018). DAPT interruption was prespecified as physician recommended cessation for
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2017.06.016